| Literature DB >> 35085349 |
Aiste Pranckeviciene1, Ausra Saudargiene2,3, Julija Gecaite-Stonciene1, Vilma Liaugaudaite1, Inga Griskova-Bulanova4, Dovile Simkute4, Rima Naginiene5, Laurynas Linas Dainauskas2, Gintare Ceidaite3, Julius Burkauskas1.
Abstract
BACKGROUND: The Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder Questionnaire- 7 (GAD-7) are short screening instruments used for detection of depression and anxiety symptoms in various settings, including general and mental health care as well as the general population. The aim of this study is to evaluate psychometric properties and factorial structure of the PHQ-9 and the GAD-7 in a sample of Lithuanian university students.Entities:
Mesh:
Year: 2022 PMID: 35085349 PMCID: PMC8794093 DOI: 10.1371/journal.pone.0263027
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Diagram of participants’ flow.
Demographic and clinical characteristics of online and interview samples.
| Total online sample (N = 1358) | Interview subsample (N = 560) | |
|---|---|---|
| Gender | ||
|
| 221 (16.3%) | 99 (17.7%) |
|
| 1134 (83.5%) | 459 (82.0%) |
|
| 3 (0.2%) | 2 (0.4%) |
| Age | 22.5 (±4.8), range 18–57 | 22.7 (±5.0), range 18–56 |
| Field of study | ||
|
| 107 (7.9%) | 43 (7.7%) |
|
| 127 (9.4%) | 62 (11.1%) |
|
| 168 (12.4%) | 51 (9.1%) |
|
| 377 (27.8%) | 151 (27.0%) |
|
| 23 (1.7%) | 7 (1.3%) |
|
| 385 (28.4%) | 174 (31.1%) |
|
| 147 (10.8%) | 62 (11.1%) |
|
| 21 (1.5%) | 8 (1.4%) |
|
| 3 (0.2%) | 2 (0.4%) |
| PHQ-9 | 9.8 (±5.7), range 0–27 | 9.7 (±5.5), range 0–26 |
| GAD -7 | 8.2 (±5.5), range 0–21 | 8.2 (±5.4), range 0–21 |
Prevalence of depressive and anxiety symptoms in Lithuanian university students.
|
| ||||
|---|---|---|---|---|
| None | Mild | Moderate | Severe | |
| Prevalence of depressive symptoms according to PHQ-9 cut-offs (5/10/15) | 259 (19.1%) | 485 (35.7%) | 338 (24.9%) | 276 (20.3%) |
| Prevalence of anxiety symptoms according to GAD-7 cut-offs (5/10/15) | 398 (29.3%) | 440 (32.4%) | 315 (23.2%) | 205 (15.1%) |
|
| ||||
| Prevalence of clinically significant psychiatric symptoms according to CIS-R cut-off (CIS-R≥12) | 175 (31.3%) | |||
| Probable primary ICD-10 diagnosis according to CID-R interview | ||||
| Specific (isolated) phobia | 8 (1.4%) | |||
| Agoraphobia | 2 (0.4%) | |||
| Obsessive-compulsive disorder | 1 (0.2%) | |||
| Social Phobia | 0 (0%) | |||
| Panic Disorder | 0 (0%) | |||
| Mixed anxiety and depressive disorder | 68 (12.1%); of these, cases with mild symptoms 59 (10.5%) | |||
| Generalized anxiety disorder | 54 (9.7%); of these, cases with mild symptoms 47 (8.4%) | |||
| Depressive episode | 81 (14.5%); of these, mild—28 (5.0%); moderate—35 (6.3%); severe—18 (3.2%) | |||
| Number of respondents meeting criteria for more than one mood or anxiety disorder according to CID-R interview | 118 (21.1%) | |||
Fig 2One-factor structure of the PHQ-9 confirmed by CFA: Chi-square value = 25.418, df = 16, p = 0.063, SRMR = 0.0151, GFI = 0.996, CFI = 0.998, RMSEA = 0.021.
Path coefficients are standardized (**p<0.001).
Fit of the CFA models tested in the study.
| Fit Values | Factor correlations | ||||||
|---|---|---|---|---|---|---|---|
| Models | χ2( |
| CFI | GFI | RMSEA (90% CI) | SRMR | |
| PHQ-9 1-F | 25.418(16) | 0.063 | 0.998 | 0.996 | 0.021 (0.000–0.036) | 0.0151 | - |
| PHQ-9 2-F | 117.181(19) | <0.001 | 0.977 | 0.957 | 0.062 (0.052–0.073) | 0.0289 | 0.82 |
| GAD-7 1-F | 11.612(8) | 0.169 | 0.999 | 0.998 | 0.018 (0.000–0.040) | 0.0085 | - |
| GAD-7 2-F | 115.477(13) | <0.001 | 0.983 | 0.976 | 0.077 (0.064–0.090) | 0.0241 | 0.95 |
F = factor; χ2 = Chi-square; df = degrees of freedom; CFI = comparative fit index; GFI = goodness of fit index; RMSEA = root mean square error of approximation; CI = confidence interval; SRMR = standardized root mean square residual.
Fig 3One-factor structure of the GAD-7 confirmed by the CFA: Chi-square value = 11.612, df = 8, p = 0.169.
Path coefficients are standardized (**p<0.001).
Correlations between the PHQ-9, GAD-7 and the CIS-R symptoms groups.
| CIS-R symptoms groups scores | PHQ-9 Total score | GAD-7 Total score |
|---|---|---|
| Suicide ideation | 0.414 | 0.363 |
| Somatic symptoms | 0.287 | 0.295 |
| Worry over physical health | 0.196 | 0.234 |
| Irritability | 0.210 | 0.262 |
| Poor concentration | 0.360 | 0.293 |
| Fatigue | 0.391 | 0.349 |
| Sleep problems | 0.349 | 0.272 |
| Depression | 0.414 | 0.415 |
| Depressive ideas | 0.447 | 0.419 |
| Phobias | 0.129 | 0.166 |
| Worry | 0.319 | 0.419 |
| Anxiety | 0.336 | 0.396 |
| Panic | 0.143 | 0.163 |
| Compulsions | 0.088 | 0.143 |
| Obsessions | 0.158 | 0.143 |
*Spearman rho<0.05,
**Spearman rho<0.01.
Fig 4ROC curve for predicting risk of anxiety and depressive disorders in students using the PHQ-9 and the GAD-7 total scores.